| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.lalchandanipathlab.com | |
| Market Cap | 9.03 Cr. | |
| Enterprise Value(EV) | 15.33 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -3.60 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 66.90 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 20.56 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 1.01 | Calculated using Price: 20.85 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.43 Cr. | 4,333,068 Shares |
| FaceValue | 10 | |
| About Dr Lalchandani Labs Ltd. | ||
| They are a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through their integrated network, they offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. | ||
| 1 Day |
|
|
| 1 Week |
|
|
| 1 Month |
|
+19.69% |
| 3 Month |
|
-14.23% |
| 6 Month |
|
-28.60% |
| 1 Year |
|
-26.61% |
| 2 Year |
|
-47.88% |
| 5 Year |
|
+4.25% |
| 10 Year |
|
| 6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 8.11 | 9.85 | 6.01 | 11.56 | 9.49 | -16.23 | |
| Return on Capital Employed (%) | 10.06 | 12.57 | 9.17 | 14.88 | 13.07 | -3.69 | |
| Return on Assets (%) | 4.23 | 6.53 | 4.3 | 7.46 | 5.6 | -8.72 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 3 | 8 | 9 | 10 | 10 | 9 | 9 | |
| Non Curr. Liab. | 1 | 1 | 2 | 3 | 3 | 3 | 3 | |
| Curr. Liab. | 2 | 1 | 2 | 3 | 5 | 5 | 5 | |
| Minority Int. | ||||||||
| Equity & Liab. | 6 | 10 | 12 | 15 | 18 | 18 | 17 | |
| Non Curr. Assets | 2 | 4 | 4 | 6 | 7 | 7 | 6 | |
| Curr. Assets | 4 | 6 | 8 | 9 | 11 | 11 | 11 | |
| Misc. Exp. not W/O | 0 | 0 | 0 | 0 | 0 | |||
| Total Assets | 6 | 10 | 12 | 15 | 18 | 18 | 17 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 3 | 5 | 6 | 10 | 11 | 5 | |
| Other Income | 0 | 0 | |||||
| Total Income | 3 | 5 | 6 | 10 | 11 | 5 | |
| Total Expenditure | -2 | -4 | -5 | -8 | -9 | -5 | |
| PBIDT | 1 | 1 | 1 | 2 | 2 | 0 | |
| Interest | 0 | 0 | 0 | 0 | -1 | -1 | |
| Depreciation | 0 | 0 | 0 | -1 | -1 | -1 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | ||
| Exceptional Items | |||||||
| PAT | 0 | 1 | 0 | 1 | 1 | -2 | |
| Adjusted EPS | 1 | 1 | 1 | 2 | 2 | -4 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 1 | 0 | 0 | 1 | 2 | ||
| Cash Fr. Inv. | -1 | -2 | -1 | -2 | -2 | 0 | |
| Cash Fr. Finan. | 2 | 4 | 1 | 2 | 0 | 0 | |
| Net Change | 1 | 1 | 0 | 1 | 1 | 0 | |
| Cash & Cash Eqvt | 1 | 2 | 2 | 3 | 4 | 3 |
|
Sat, 20 Apr 2024
Compliance Certificate Under Regulation 40(10) Of SEBI (LODR) Regulations 2015 compliance certificate under Reg 40(10) for the quarter ended March 2024 |
|
Wed, 17 Apr 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations For The Year Ended March 2024 Compliance Certificate for the year ended March 2024 |
|
Mon, 15 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate by RTA under Reg 74(5) for the quarter ended March 2024 |
| Fri, 12 Apr 2024 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
